Delivery Order SPE2DE24D0013-SPE2D626F20M5
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This delivery order, designated XPRSMVP-10, was issued without a set-aside designation and represents procurement of molecular diagnostic supplies and reagents for the GeneXpert diagnostic platform. The contract is performed at Cepheid's location in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $9,216.80 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRSMVP-10 (Contract Number 4570254413), represents a continuation of the federal government's reliance on Cepheid's diagnostic capabilities. The contract utilizes no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,680 with an ultimate completion date of November 13, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued without a set-aside designation, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. As a manufacturer of advanced diagnostic systems and reagents, Cepheid supplies the federal...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $13,281.60 by the Defense Logistics Agency Medical Supply Chain on November 20, 2025, with an ultimate completion date of November 28, 2025. The contract, designated as XPRSTREPA-10, is a non-set-aside procurement for diagnostic supplies and reagents. As a leading federal supplier of advanced molecular diagnostic systems, Cepheid specializes in GeneXpert diagnostic platform solutions and...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $10,200.00 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025. The firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, is designated as XPRS4PLEX-10 and carries no set-aside designation. This delivery order falls under Cepheid's broader contracting relationship with federal healthcare agencies, where...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,597.30 under a Defense Logistics Agency Medical Supply Chain contract (4570223169). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 16, 2025, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F20M5Delivery Order
Cepheid Inc. was awarded a firm fixed-price delivery order valued at $1,750 by the Defense Logistics Agency Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This delivery order, issued under contract GXMRSA-NXG-10, requires performance in Sunnyvale, California, where Cepheid maintains its headquarters. The contract contains no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement market. As a leading manufacturer of advanced molecular diagnostic systems and reagents, Cepheid supplies the Defense Logistics Agency with diagnostic testing supplies, test kits, and reagents supporting federal healthcare operations. Cepheid has established itself as a primary federal supplier of diagnostic solutions through its GeneXpert diagnostic platform, serving multiple defense and civilian healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company holds two significant Indefinite Delivery Contracts with the VA valued at $6.7 million and $32.8 million through 2029 and 2030, respectively, which provide the framework for extensive ongoing procurement of molecular diagnostic solutions. Cepheid's core competencies encompass rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, tuberculosis, and drug-resistant pathogens, supported by comprehensive maintenance and repair services across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/14/25 |